Statement Of Income And Retained Earnings

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7586092

Concept 2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
2021-04-01 to
2021-09-30
2021-04-01 to
2021-09-30
2021-04-01 to
2021-09-30
2021-04-01 to
2021-09-30
2021-04-01 to
2021-09-30
2021-04-01 to
2021-09-30
Statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
231,000,000 JPY
3,141,000,000 JPY
-473,000,000 JPY
-20,000,000 JPY
3,352,000,000 JPY
2,879,000,000 JPY
3,000,000,000 JPY
-26,000,000 JPY
-342,000,000 JPY
2,657,000,000 JPY
229,000,000 JPY
2,797,000,000 JPY
Non-operating income
Non-operating income
236,000,000 JPY
254,000,000 JPY
Non-operating expenses
Non-operating expenses
128,000,000 JPY
168,000,000 JPY
Ordinary profit (loss)
2,987,000,000 JPY
2,743,000,000 JPY
Extraordinary income
Extraordinary income
32,000,000 JPY
JPY
Extraordinary losses
Extraordinary losses
JPY
6,882,000,000 JPY
Profit (loss) before income taxes
3,019,000,000 JPY
-4,139,000,000 JPY
Income taxes - current
693,000,000 JPY
117,000,000 JPY
Income taxes - deferred
-19,000,000 JPY
-1,460,000,000 JPY
Profit (loss)
2,346,000,000 JPY
-2,796,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.